Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 From theoretical synergy to clinical supra-additive toxicity.

× No keyword cloud information.

12 in total

Review 1. Designs and challenges for personalized medicine studies in oncology: focus on the SHIVA trial.

Authors: Christophe Le Tourneau; Maud Kamal; Olivier Trédan; Jean-Pierre Delord; Mario Campone; Anthony Goncalves; Nicolas Isambert; Thierry Conroy; David Gentien; Anne Vincent-Salomon; Anne-Lise Pouliquen; Nicolas Servant; Marc-Henri Stern; Anne-Gaëlle Le Corroller; Sébastien Armanet; Thomas Rio Frio; Xavier Paoletti
Journal: Target Oncol Date: 2012-11-17 Impact factor: 4.493

Review 2. Sunitinib in the treatment of metastatic renal cell carcinoma.

Authors: Thomas A Schmid; Martin E Gore
Journal: Ther Adv Urol Date: 2016-08-23

Review 3. Novel insights into mesothelioma biology and implications for therapy.

Authors: Timothy A Yap; Joachim G Aerts; Sanjay Popat; Dean A Fennell
Journal: Nat Rev Cancer Date: 2017-07-25 Impact factor: 60.716

4. Combination of Temsirolimus and tyrosine kinase inhibitors in renal carcinoma and endothelial cell lines.

Authors: Bénédicte Martin; Julien Edeline; Jean-Jacques Patard; Emmanuel Oger; Florence Jouan; Gaëlla Boulanger; Sélim Zerrouki; Cécile Vigneau; Nathalie Rioux-Leclercq
Journal: J Cancer Res Clin Oncol Date: 2012-02-10 Impact factor: 4.553

Review 5. Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials.

Authors: Christophe Le Tourneau; Maud Kamal; Apostolia-Maria Tsimberidou; Philippe Bedard; Gaëlle Pierron; Céline Callens; Etienne Rouleau; Anne Vincent-Salomon; Nicolas Servant; Marie Alt; Roman Rouzier; Xavier Paoletti; Olivier Delattre; Ivan Bièche
Journal: J Natl Cancer Inst Date: 2015-11-23 Impact factor: 13.506

Review 6. Combine and conquer: challenges for targeted therapy combinations in early phase trials.

Authors: Juanita S Lopez; Udai Banerji
Journal: Nat Rev Clin Oncol Date: 2016-07-05 Impact factor: 66.675

Review 7. Hypertension and Angiotensin System Inhibitors in Patients with Metastatic Renal Cell Carcinoma.

Authors: Lisa Derosa; Hassane Izzedine; Laurence Albiges; Bernard Escudier
Journal: Oncol Rev Date: 2016-11-24

8. Combinations of targeted therapies in human cancers.

Authors: Didier Decaudin; Christophe Le Tourneau
Journal: Aging (Albany NY) Date: 2016-10-26 Impact factor: 5.682

9. Nilotinib, an approved leukemia drug, inhibits smoothened signaling in Hedgehog-dependent medulloblastoma.

Authors: Kirti Kandhwal Chahal; Jie Li; Irina Kufareva; Milind Parle; Donald L Durden; Robert J Wechsler-Reya; Clark C Chen; Ruben Abagyan
Journal: PLoS One Date: 2019-09-20 Impact factor: 3.240

Review 10. Anti-VEGF Cancer Therapy in Nephrology Practice.

Authors: Hassan Izzedine
Journal: Int J Nephrol Date: 2014-08-24